Urinary system disorder

Related records

Broader conditions (3)

• Disease
• Disease by body system or component
• Human disease

Narrower conditions (770)

• Acalculous cholecystitis
• Acquired cystic disease-associated renal cell carcinoma
• Acquired distal renal tubular acidosis
• Acquired Fanconi syndrome
• Acute cystitis
• Acute diffuse glomerulonephritis
• Acute gonococcal cystitis
• Acute kidney injury
• Acute kidney tubular necrosis
• Acute papillary necrosis
• Acute poststreptococcal glomerulonephritis
• Acute proliferative glomerulonephritis
• Acute pyelonephritis
• Acute tubulointerstitial nephritis
• Acute urate nephropathy
• Adenovirus renal infection
• Adrenal cortex carcinoma
• Adrenocortical carcinoma, hereditary
• Adult familial nephronophthisis-spastic quadriparesia syndrome
• Adult Fanconi syndrome

Trials (233)

• (SWL) Versus (ODT) Versus Combined SWL And ODT For Radiolucent Stone
• 10 Minutes Prewarming and Warmed Intravenous Fluid on Core Temperature
• 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
• A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects
• A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With Methenamine Hippurate Compared to the Standard of Care (Either Prophylactic (Low) Dose Antibiotic Treatment or Methenamine Hippurate) in Females With Chronic Urinary Tract Infection
• A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
• A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery
• A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
• A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria
• A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice
• A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC)
• A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
• A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)
• A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease
• A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept
• A Sham-Controlled Study to Evaluate the Safety and Efficacy of a Smart, Self-Adjusting, Surgery-Free, Wearable Bladder Neuromodulation System for Overactive Bladder
• A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
• A Study of B-701 in Combination With Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
• A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)
• A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

Approved drugs (1)

• Ethacrynic acid

Other linked drugs (6)

• Cisatracurium
• Diatrizoic acid
• Edetate calcium disodium anhydrous
• Edetate calcium disodium monohydrate
• Iopentol
• Phloroglucinol